domingo, 29 de diciembre de 2019

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study. Wuerstlein R et al. Breast cancer research and treatment 2019 Jun 175(2) 389-399

Main|Search|PHGKB

DNA


Last Posted: Dec 02, 2019


No hay comentarios:

Publicar un comentario